ClinicalTrials.govpublic full text
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
recurrent plasma cell myeloma, refractory plasma cell myeloma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 230395
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.